The Centers for Medicare & Medicaid Services released a frequently asked questions document for pharmacies regarding the Preexposure Prophylaxis (PrEP) Using Antiretroviral Drugs to Prevent HIV National Coverage Determination (NCD) in Medicare Part B expected to be made public and effective in late September 2024. The FAQ addresses background, enrollment, and billing information.
The final NCD is expected to be similar to the proposed NCD that was published on July 12, 2023, and CMS advises pharmacies to be prepared for this transition. CMS is sharing as much information as possible before issuing the final NCD to avoid disruptions for beneficiaries.
The FAQ document is in follow up to CMS’ publication of a fact sheet in May 2024. NCPA submitted comments on the proposed NCD back in August 2023.
